Cg Oncology Overview
Valuation check: CGON's PEG ratio is 30.42, above the sector sector average of -7.59.
Get informed when a big investor buys or sells
+ Follow30.42
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Cg Oncology posts a PEG ratio of 30.42. That is above the sector sector average of -7.59. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a PEG ratio near -7.59 is typical. Cg Oncology's 30.42 is higher that level. That is roughly 500.8% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Cg Oncology's PEG ratio of 30.42 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.
Context for CGON's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -7.59), and (3) consistency with growth and profitability. This page covers the first two; Cg Oncology's other metric pages and overview cover the third.
